Pure Global

LIQUIZONE Bilirubin (Total & Direct) - Indonesia BPOM Medical Device Registration

LIQUIZONE Bilirubin (Total & Direct) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101813337. The device is manufactured by MEDSOURCE OZONE BIOMEDICALS PVT., LTD. from India, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is SUMIFIN CITRA ABADI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
LIQUIZONE Bilirubin (Total & Direct)
Analysis ID: AKL 20101813337

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

India

Authorized Representative

SUMIFIN CITRA ABADI

AR Address

Jl. Alam Sutera Boulevard Alam Sutera Town Center (ASTC) Blok 10D No.19, Kel. Pakulonan, Kec. Serpong Utara - Tangerang Selatan 15325

Registration Date

Aug 26, 2024

Expiry Date

May 22, 2029

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing